Guest guest Posted January 12, 2011 Report Share Posted January 12, 2011 The Impact of Donor Race on Recurrent Hepatitis C after Liver Transplantation Transplantation Proceedings Excess mortality in patients with advanced chronic hepatitis C treated with long–term peginterferon Hepatology Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors Telaprevir (VX–950) and Danoprevir (ITMN–191) Hepatology Pegylated Interferon for Treatment of Chronic Hepatitis C in Hemodialysis Patients in Croatia Kidney and Blood Pressure Research Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 12, 2011 Report Share Posted January 12, 2011 The Impact of Donor Race on Recurrent Hepatitis C after Liver Transplantation Transplantation Proceedings Excess mortality in patients with advanced chronic hepatitis C treated with long–term peginterferon Hepatology Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors Telaprevir (VX–950) and Danoprevir (ITMN–191) Hepatology Pegylated Interferon for Treatment of Chronic Hepatitis C in Hemodialysis Patients in Croatia Kidney and Blood Pressure Research Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.